This compound is not intended for human consumption or therapeutic application
PMC12313605 Fenwick S, et al
METTL3 Attenuates LPS-Induced Inflammatory Response in Macrophages via NF-b Signaling Pathway
Reduced intravenous glutathione in the treatment of early Parkinsons disease
In exogenous research applications, the synthetic BPC-157 fragment has been evaluated across tissue types spanning the entire musculoskeletal system, gastrointestinal tract, liver, pancreas, cardiovascular system, and central nervous system producing consistently positive results across an unusually wide range of injury and dysfunction models
For more information on how to adjust your diet to reduce cardiovascular risk, check out this post on diet and cardiovascular risk